The U.S. Food and Drug Administration (FDA) has approved a new use for a medicine called Caplyta, also known by its scientific name lumateperone. This drug can now be used alongside traditional antidepressants to help adults who suffer from major depressive disorder, commonly known as depression.
This approval marks an important step forward in the treatment of depression, as many people struggle to find effective relief with existing therapies. By combining Caplyta with standard antidepressants, patients may experience faster and improved outcomes.
The development offers new hope for individuals battling this challenging condition and underscores the ongoing efforts to enhance mental health care.
The post New depression drug can offer faster relief appeared first on Knowridge Science Report.
https://knowridge.com/2025/11/new-depression-drug-can-offer-faster-relief/
